Home › Amyloidosis

Amyloidosis clinical trials recruiting in the U.S.

29 studies for Amyloidosis are recruiting participants at sites across the United States.

Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.

Cities with the most studies

• Boston, MA11 studies
• Rochester, MN10 studies
• New York City, NY10 studies
• Dallas, TX9 studies
• Philadelphia, PA7 studies
• St. Louis, MO6 studies
• Baltimore, MD6 studies
• Houston, TX6 studies
• Durham, NC6 studies
• Portland, OR6 studies
• Washington, DC5 studies
• San Diego, CA5 studies
• Chicago, IL5 studies
• Nashville, TN5 studies
• Cleveland, OH5 studies
• Detroit, MI4 studies
• Charlotte, NC4 studies
• Jacksonville, FL4 studies
• Los Angeles, CA4 studies
• Richmond, VA4 studies
• San Francisco, CA4 studies
• Seattle, WA4 studies
• Edison, NJ3 studies
• Kansas City, KS3 studies
• Austin, TX3 studies
• Columbus, OH3 studies
• Aurora, CO3 studies
• Indianapolis, IN3 studies
• New Haven, CT3 studies
• Kansas City, MO3 studies
• Mountain View, CA3 studies
• Miami, FL3 studies
• Salt Lake City, UT3 studies
• Arlington, VA3 studies
• Atlanta, GA3 studies
• Charleston, SC3 studies

By state

• Arizona3 studies
• California8 studies
• Colorado5 studies
• Connecticut4 studies
• District of Columbia4 studies
• Florida8 studies
• Georgia3 studies
• Illinois5 studies
• Indiana3 studies
• Kansas3 studies
• Maryland7 studies
• Massachusetts11 studies
• Michigan5 studies
• Minnesota10 studies
• Missouri7 studies
• New Jersey3 studies
• New York10 studies
• North Carolina10 studies
• Ohio6 studies
• Oregon6 studies
• Pennsylvania7 studies
• South Carolina4 studies
• Tennessee7 studies
• Texas11 studies
• Utah3 studies
• Virginia4 studies
• Washington4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.